Peer Review History
Original SubmissionSeptember 9, 2023 |
---|
PONE-D-23-28989Cat and Dog Owners’ Expectations and Attitudes towards Advanced Veterinary Care (AVC) in the UK, Austria and Denmark.PLOS ONE Dear Dr. Springer, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Jan 14 2024 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Francesca Baratta, PharmD, PhD Academic Editor PLOS ONE Journal requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. Note from Emily Chenette, Editor in Chief of PLOS ONE, and Iain Hrynaszkiewicz, Director of Open Research Solutions at PLOS: Did you know that depositing data in a repository is associated with up to a 25% citation advantage (https://doi.org/10.1371/journal.pone.0230416)? If you’ve not already done so, consider depositing your raw data in a repository to ensure your work is read, appreciated and cited by the largest possible audience. You’ll also earn an Accessible Data icon on your published paper if you deposit your data in any participating repository (https://plos.org/open-science/open-data/#accessible-data). 3. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information. 4. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: I Don't Know Reviewer #2: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: In this questionnaire survey study, sent to cat and dog owners, representative samples, in the UK, Austria and Denmark, the authors investigated owners’ expectations and attitudes towards advanced veterinary care. Also, the factors that might influence those views were analysed. In line with arguments presented within the veterinary community during the resent years, it was speculated there may be negative consequences for the well-being of the animals: if euthanasia actually is appropriate, owners with strong emotional attachments to their pets may pursue treatments that significantly reduce the quality of the animal’s life, with the aim to prolong their pet’s life. This contributes to an ethical discussion, what is right, or wrong, is the customer always right? Another aspect is the concept of ‘caregiver burden’ for the pet owner, emotional distress, financial and practical challenges that comes with AVC. It was investigated if this was correlated to level of emotional attachment. Furthermore, it was studied if owners who expect AVC to be available for their animal were more likely to be willing to participate in a clinical research study. The authors reported 59% of the pet owners believed that their pets should have access to the same treatment options as humans. This is indeed an interesting result, and I reach for a clarification: what does “access” mean? Should be given (moving towards “avoid euthanasia at all cost”)? Should be available, ie the treatment option should simply be there, financial aspects to be considered / taken into consideration etc? These initial comments are along the path of “are the questions to a high or low degree open to interpretation”? However, if there was room for interpretation, this should have been caught in the test run, which was appropriately performed. Also, this is covered in section Limitations, “some may have remained ambiguous and therefore open to being interpreted differently by individuals”. The comments are within Minor revision, mainly related to style preferences. The only Major revision is how to deal with cultural differences between countries, and inclusion/exclusion criteria (Should respondents who work within the veterinary field (6.8%) be excluded?). Please see below. Overall, this is a rather unique study, important not only for vets, also for our health care industry, including insurance companies. Has modern veterinary care “gone too far”? Opinions on AVC on this topic have not been sought directly from pet owners themselves. In addition, some very interesting cultural differences between countries were found, also differences between genders. Publication of this manuscript is clearly justified. Ethics: was there only a permit for the Kingdom of Denmark, not the other countries? If so, is this appropriate? Abstract Line 55-57: please consider if the wording is appropriate, neutral and disagree. Line 63: Our findings will help inform veterinarians… not only veterinarians; also other health care providers, and others related to our industry (insurance companies). Introduction Line 132: veterinarian salaries… suggest “staff salaries”, as there are several professions involved. Line 144: suggest “was the focus” Line 146-158: Please consider significantly shorten this section; parts of the text may be more suitable in the Discussion. Line 181: Suggest “This study addressed” Line 193: Suggest “were explored” Line 198-202: Please consider moving to first section Discussion; suggest include insurance companies. M&M Line 206: can the Danes give permission for a study performed in other countries? Perhaps the answer is yes, taken into consideration where the Norstat company is based? Results Should respondents who work within the veterinary field (6.8%) be excluded? Can they be considered “representative pet owners”? Line 425-426: Please consider the appropriate wording – does the text accurately describe the difference between 45% (neutral) and 40% (disagree)? …neutral on the question of whether advanced care has ‘gone too far’ (45.3%), and tended to disagree with the statement that it is ‘unnecessary’ (40.1%). Discussion Line 532: no need to repeat results – please consider removing p-values. Line 555: There are several possible reasons for the between-country differences; apart from size of clinics, other cultural differences may play a large role (what attitudes towards animals are we transferring to our children?). A clue is found in the abundance of pets; UK pet owners often have several more pets per household than citizens of other countries do. Does a higher proportion of households in the UK have pets compared to other countries? My message is that clearly there are differences between countries in attitudes, and this study nicely demonstrates so. The question is, are you overemphasizing the importance of size (smiley)? Isn’t there is a lot more behind those differences than mean size of practise? Please consider broadening the text. This may also resolve line 559-60 “which is difficult to explain”. The crosscheck study would be to interview vets in the UK (or other nation) that originate from another country/culture and have working experience from that other country. What attitudes amongst our customers do we recognise between countries, and what attitudes differ? A potential topic for another study… Line 570-576: can the topic of “culture and attitude” also be incorporated? It would seem dogs are generally considered more valuable than cats in several countries, as dogs are more likely to be insured… and owners are in general more willing to spend £ on their dogs (than cats). This might be a poor parallel to societal hierarchy, but in general, the MD and CEO are considered “more important” than another random profession; is this part of the explanation, dogs are simply more valuable (where attachment is only one factor)? Line 606-609: “Differences noted between countries could also reflect cultural differences”. Thank you! Reviewer #2: A very interesting manuscript with results that will be valuable for those working in veterinary medicine. Abstract Line 50 – ‘…questionnaire survey…’ – suggest changing to ‘…questionnaire used to survey cat and dog owners…’ Introduction -There is information about the benefits of AVC, but is there any data suggesting reduced success rates in pets compared to humans for certain types of AVC? Or potential health, behavior, other, consequences for pets? Line 99 – what exactly is in the ‘interest’ of the pet? Instead, suggest adding a sentence with details on the potential animal welfare implications, and providing more examples to back up the claim that AVC may not be in the best ‘interest’ of pets. Line 110 – I don’t think veterinarians are highly motivated to use all new technologies (example virtual care via telemedicine), but I think you’re referring to specific types of technologies here… can you be more specific? Lines 116-119 don’t seem relevant, suggest taking out Line 146 – can you add ‘We predict…’ at the beginning of this sentence? It sounds more like a statement the way it’s currently written Line 182 – wouldn’t the second part of research question 1 depend on whether a pet owner has had a pet with a serious health issue or was given the option/ recommendation to see a specialist? Did you screen for this first, then see the number/percentage who chose to see a specialist of those that have had a pet with a serious health issue that wasn’t being managed by their primary veterinarian? Line 198 – suggest changing ‘…our study will help to give…’ to ‘… our study aims to provide…’ Materials and Methods Line 213 – is there evidence that NORSTAT can reach a representative sample? In other words, are pet owners that choose to participate in NORSTAT surveys, different than those that choose not to participate? Is there any data/research on this? Line 214 – states ‘…., including pet owners.’ Did your survey include non-pet owners? If so, why? This part is confusing because in the introduction you specify your target population is pet owners. Line 215 – What was the randomization procedure? For example, a random number generator. Please specify. Line 215 – How do you know those from NORSTAT’s pre-established citizen panel is representative of the average pet owner? Was there an incentive (i.e., monetary) to participate? Line 227 – 230 about the consent process is confusing/wordy, suggest being more concise. For example, participants provided consent by clicking a ‘next’ button at the bottom of the consent form to proceed to the questionnaire. Line 260 – Survey design and measurement – can you move this section up before recruitment of participants? The organization of the methods isn’t in order of how the study was conducted, which is a bit confusing. Suggest re-organizing the sections of the Materials and Methods to be more sequential, which I think may help with clarity/understanding. For example, order of sub-sections could be: Ethics, survey design and measurement, survey development, recruitment Line 274 – how does asking them to chose ‘their favorites pet’ bias the results? Why not ask them to choose the pet whose name comes first in the alphabet? Also, do you know if pet owners with both dogs and cats, commonly chose to answer questions for their dog versus cat? I would think answering for their favorite pet would be the pet they're more likely to spend money on. Data Analyses Line 321 – for the ‘animal species’ categorical variables in the models, did you not also have a ‘both cat and dog owner’ category? Or for these models did you only include cat owner, and dog owner, not those who are both? Line 322 – Why include ‘prefer not to say/I don’t know’ option for the total gross household income per year variable? What does this information provide? Line 328-329 – Ok now I understand! Suggest moving this information up so it’s clear in your methods section. Also suggest moving this up when you first talk about that explanatory variable in the data analyses section. Can you also provide rationale for choosing to do this? Overall there is no information about how you assessed model fit, or tested model assumptions. Please add this. Results Line 250 -chi-square tests are inferential tests, and not descriptive. Suggest changing the title of this section. Discussion Line 583 – Could another explanation be that dog owners are more likely to spend more money on their pets than cat owners? Overall, a great job summarizing the results and incorporating with current literature. Tables/Figures/Supporting Information: -Please provide a more descriptive caption for tables, as the reader should be able to interpret the tables without having to read the manuscript. For example, please add ‘N’, outcome variable categories, population, etc. ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
Revision 1 |
Cat and Dog Owners’ Expectations and Attitudes towards Advanced Veterinary Care (AVC) in the UK, Austria and Denmark. PONE-D-23-28989R1 Dear Dr. Corr, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Francesca Baratta, PharmD, PhD Academic Editor PLOS ONE Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: All comments have been addressed Reviewer #2: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: The authors have commented and addressed the expressed concerns and suggestions appropriately. This is a fine manuscript, well worthy of publication. Reviewer #2: (No Response) ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No ********** |
Formally Accepted |
PONE-D-23-28989R1 PLOS ONE Dear Dr. Corr, I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team. At this stage, our production department will prepare your paper for publication. This includes ensuring the following: * All references, tables, and figures are properly cited * All relevant supporting information is included in the manuscript submission, * There are no issues that prevent the paper from being properly typeset If revisions are needed, the production department will contact you directly to resolve them. If no revisions are needed, you will receive an email when the publication date has been set. At this time, we do not offer pre-publication proofs to authors during production of the accepted work. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few weeks to review your paper and let you know the next and final steps. Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. If we can help with anything else, please email us at customercare@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Francesca Baratta Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .